Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
PrEP scales up, HIV incidence declines

As use of PrEP continues to grow, epidemiological evidence is starting to show a link between increased use and declines in new HIV infections.

Published
09 August 2018
From
BETA blog
Studies show dolutegravir monotherapy is an unsafe switch option

Using dolutegravir alone, as maintenance treatment after achieving undetectable viral load on a three-drug regimen, results in an unacceptable rate of viral rebound and is unethical in

Published
09 August 2018
By
Keith Alcorn
HIV self-testing kits to become available on high street with Superdrug leading initiative

HIV self-testing kits are to be available to buy on the high street for the first time, it has been announced. Superdrug will become the first retailer to offer the kit across its 200 stores for £33.99.

Published
08 August 2018
From
ITV
Undetectable means untransmittable: what you need to know about HIV

Dr Paddy Mallon, a consultant at the Mater Private Hospital in Dublin and a specialist in infectious diseases, believes the government and public health bodies need to do more. “HIV as a condition has completely changed since the last public health campaign in Ireland over a decade ago,” says Mallon, who is also director of the UCD HIV Molecular Research Group.

Published
08 August 2018
From
Irish Times
New Zealand: Pharmac widens access to 'revolutionary' HIV-prevention drug

Hundreds of prescriptions for a "revolutionary" HIV-prevention drug have been approved in the first few months of it being more widely available. Pharmac expanded access to Truvada in March. In the first three months, 695 people got the medication for the first time, paying $5 for a three-month prescription.

Published
08 August 2018
From
Newshub
Naltrexone helps HIV positive individuals reduce heavy alcohol use

Extended-release naltrexone -- an injection that decreases heavy drinking in the general population when taken in conjunction with counseling -- appears to help HIV-positive individuals reduce their number of heavy drinking days too, say Yale researchers.

Published
08 August 2018
From
Science Daily
58% of Those With Diagnosed HIV Were Virally Suppressed in 2014

This is according to a CDC analysis of surveillance records from 37 states and Washington, DC.

Published
08 August 2018
From
Poz
HIV infection is a risk factor for liver fat accumulation

People living with HIV are about twice as likely to develop steatosis, or fat accumulation in the liver, even if they don't have hepatitis B or C co-infection,

Published
08 August 2018
By
Liz Highleyman
Gilead Said PrEP To Prevent HIV Was 'Not A Commercial Opportunity.' Now It's Running Ads For It

The commercial, aptly titled "I'm on the Pill," is part of a marketing push that has helped turned the use of Truvada for preventing HIV into a $1.3 billion blockbuster, almost 5% of Gilead's annual sales.

Published
07 August 2018
From
Forbes Magazine
Access to opioid agonist therapy in Russia: time for reform (free registration required)

The efforts to halt the spread of HIV in Russia are hindered by the policies of its government, which has scaled back harm reduction efforts and denied access to opioid agonist treatment to 1·8 million people who inject drugs in Russia, many of whom inject opioids.

Published
07 August 2018
From
The Lancet

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.